101 related articles for article (PubMed ID: 1399724)
1. The significance of post-irradiation prostate biopsy with long-term follow-up.
Kuban DA; el-Mahdi AM; Schellhammer P
Int J Radiat Oncol Biol Phys; 1992; 24(3):409-14. PubMed ID: 1399724
[TBL] [Abstract][Full Text] [Related]
2. Improved local control and survival for surgically staged patients with locally advanced prostate cancer treated with up-front low dose rate iridium-192 prostate implantation and external beam irradiation.
Stromberg J; Martinez A; Benson R; Garton G; Diokno A; Gonzalez J; Zincke H; Schray M; Edmundson G; Brabbins D
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):67-75. PubMed ID: 8270460
[TBL] [Abstract][Full Text] [Related]
3. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.
Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):664-73. PubMed ID: 11849788
[TBL] [Abstract][Full Text] [Related]
4. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
Stock RG; Stone NN; DeWyngaert JK; Lavagnini P; Unger PD
Cancer; 1996 Jun; 77(11):2386-92. PubMed ID: 8635111
[TBL] [Abstract][Full Text] [Related]
5. The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation.
Fuks Z; Leibel SA; Wallner KE; Begg CB; Fair WR; Anderson LL; Hilaris BS; Whitmore WF
Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):537-47. PubMed ID: 1869452
[TBL] [Abstract][Full Text] [Related]
6. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma.
Ragde H; Elgamal AA; Snow PB; Brandt J; Bartolucci AA; Nadir BS; Korb LJ
Cancer; 1998 Sep; 83(5):989-1001. PubMed ID: 9731904
[TBL] [Abstract][Full Text] [Related]
7. The effects of local and regional treatment on the metastatic outcome in prostatic carcinoma with pelvic lymph node involvement.
Leibel SA; Fuks Z; Zelefsky MJ; Whitmore WF
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):7-16. PubMed ID: 8270461
[TBL] [Abstract][Full Text] [Related]
8. The effect of disease and treatment-related factors on biopsy results after prostate brachytherapy: implications for treatment optimization.
Stock RG; Stone NN; Kao J; Iannuzzi C; Unger P
Cancer; 2000 Oct; 89(8):1829-34. PubMed ID: 11042580
[TBL] [Abstract][Full Text] [Related]
9. Prostate biopsy after definitive treatment by interstitial 125iodine implant or external beam radiation therapy.
Schellhammer PF; el-Mahdi AM; Higgins EM; Schultheiss TE; Ladaga LE; Babb TJ
J Urol; 1987 May; 137(5):897-901. PubMed ID: 3106654
[TBL] [Abstract][Full Text] [Related]
10. Prognosis in patients with local recurrence after definitive irradiation for prostatic carcinoma.
Kuban DA; el-Mahdi AM; Schellhammer PF
Cancer; 1989 Jun; 63(12):2421-5. PubMed ID: 2720588
[TBL] [Abstract][Full Text] [Related]
11. The clinical significance of a positive post-irradiation prostatic biopsy without metastases.
Prestidge BR; Kaplan I; Cox RS; Bagshaw MA
Int J Radiat Oncol Biol Phys; 1992; 24(3):403-8. PubMed ID: 1399723
[TBL] [Abstract][Full Text] [Related]
12. Posttreatment biopsy results following interstitial brachytherapy in early-stage prostate cancer.
Prestidge BR; Hoak DC; Grimm PD; Ragde H; Cavanagh W; Blasko JC
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):31-9. PubMed ID: 9054874
[TBL] [Abstract][Full Text] [Related]
13. Technical and tumor-related factors affecting outcome of definitive irradiation for localized carcinoma of the prostate.
Perez CA; Lee HK; Georgiou A; Logsdon MD; Lai PP; Lockett MA
Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):581-91. PubMed ID: 8330986
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer.
Zelefsky MJ; Whitmore WF
J Urol; 1997 Jul; 158(1):23-9; discussion 29-30. PubMed ID: 9186315
[TBL] [Abstract][Full Text] [Related]
15. Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer.
Merrick GS; Butler WM; Galbreath RW; Lief JH
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):41-8. PubMed ID: 11516849
[TBL] [Abstract][Full Text] [Related]
16. Reevaluation of prostate biopsy after definitive radiation therapy.
Miller EB; Ladaga LE; el-Mahdi AM; Schellhammer PF
Urology; 1993 Apr; 41(4):311-6. PubMed ID: 8470314
[TBL] [Abstract][Full Text] [Related]
17. Five-year outcomes after iodine-125 seed brachytherapy for low-risk prostate cancer at three cancer centres in the UK.
Dickinson PD; Malik J; Mandall P; Swindell R; Bottomley D; Hoskin P; Logue JP; Wylie JP
BJU Int; 2014 May; 113(5):748-53. PubMed ID: 24053230
[TBL] [Abstract][Full Text] [Related]
18. Distant and local recurrence in patients with biochemical failure after prostate brachytherapy.
Stock RG; Cesaretti JA; Unger P; Stone NN
Brachytherapy; 2008; 7(3):217-22. PubMed ID: 18635024
[TBL] [Abstract][Full Text] [Related]
19. Prostatic biopsy after irradiation therapy for prostatic cancer.
Scardino PT; Wheeler TM
Urology; 1985 Feb; 25(2 Suppl):39-46. PubMed ID: 3918375
[TBL] [Abstract][Full Text] [Related]
20. Iodine-125 implants versus external beam therapy for stages A2, B, and C prostate cancer.
Morton JD; Peschel RE
Int J Radiat Oncol Biol Phys; 1988 Jun; 14(6):1153-7. PubMed ID: 3133328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
